Skip to Main Content

Author Details

Stefan M Pfister
Hopp Children's Cancer Center Heidelberg (KiTZ)
2001
540
120
Antoine Forget (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
37875569Author Correction: Multiomic neuropathology improves diagnostic accuracy in pediatric neuro-oncology.Nat Med2024
37875569Author Correction: Multiomic neuropathology improves diagnostic accuracy in pediatric neuro-oncology.Nat Med2024
35977048BH3 mimetics targeting BCL-XL impact the senescent compartment of pilocytic astrocytoma.Neuro Oncol2023
35882450The first-in-class ERK inhibitor ulixertinib shows promising activity in mitogen-activated protein kinase (MAPK)-driven pediatric low-grade glioma models.Neuro Oncol2023
36437415Amplification of the PLAG-family genes-PLAGL1 and PLAGL2-is a key feature of the novel tumor type CNS embryonal tumor with PLAGL amplification.Acta Neuropathol2023
35977048BH3 mimetics targeting BCL-XL impact the senescent compartment of pilocytic astrocytoma.Neuro Oncol2023
37679810Transcriptional immunogenomic analysis reveals distinct immunological clusters in paediatric nervous system tumours.Genome Med2023
37999877Generation of patient-derived pediatric pilocytic astrocytoma in-vitro models using SV40 large T: evaluation of a modeling workflow.J Neurooncol2023
37776353Genetical and epigenetical profiling identifies two subgroups of pineal parenchymal tumors of intermediate differentiation (PPTID) with distinct molecular, histological and clinical characteristics.Acta Neuropathol2023
37287693A multi-institutional retrospective pooled outcome analysis of molecularly annotated pediatric supratentorial <i>ZFTA-</i>fused ependymoma.Neurooncol Adv2023
37287580Pediatric meningiomas: A literature review and diagnostic update.Neurooncol Adv2023
37093271Transcriptome analysis stratifies second-generation non-WNT/non-SHH medulloblastoma subgroups into clinically tractable subtypes.Acta Neuropathol2023
36715306Risk prediction in early childhood sonic hedgehog medulloblastoma treated with radiation-avoiding chemotherapy: Evidence for more than 2 subgroups.Neuro Oncol2023
37277823Group-specific cellular metabolism in Medulloblastoma.J Transl Med2023
370855393D genome mapping identifies subgroup-specific chromosome conformations and tumor-dependency genes in ependymoma.Nat Commun2023
36964296Pediatric-type high-grade neuroepithelial tumors with CIC gene fusion share a common DNA methylation signature.NPJ Precis Oncol2023
37400873BRCA1/2 potential founder variants in the Jordanian population: an opportunity for a customized screening panel.Hered Cancer Clin Pract2023
37020198The potential of PARP as a therapeutic target across pediatric solid malignancies.BMC Cancer2023
36765089Loss of phosphatase CTDNEP1 potentiates aggressive medulloblastoma by triggering MYC amplification and genomic instability.Nat Commun2023
36959034Corrigendum to 'Molecular diagnostics enables detection of actionable targets: the Pediatric Targeted Therapy 2.0 registry' [Eur J Cancer 180 (2023) 71-84].Eur J Cancer2023
36576005Revana: a comprehensive tool for regulatory variant analysis and visualization of cancer genomes.Bioinformatics2023
36495208Reply to Evans and Woodward.J Natl Cancer Inst2023
37075810LOGGIC Core BioClinical Data Bank: Added clinical value of RNA-Seq in an international molecular diagnostic registry for pediatric low-grade glioma patients.Neuro Oncol2023
37015036Combination Early-Phase Trials of Anticancer Agents in Children and Adolescents.J Clin Oncol2023
37014508Molecular characterisation defines clinically-actionable heterogeneity within Group 4 medulloblastoma and improves disease risk-stratification.Acta Neuropathol2023
36759899Common molecular features of H3K27M DMGs and PFA ependymomas map to hindbrain developmental pathways.Acta Neuropathol Commun2023
36702933Comprehensive analysis of mutational signatures reveals distinct patterns and molecular processes across 27 pediatric cancers.Nat Cancer2023
36635768Comparison of transcriptome profiles between medulloblastoma primary and recurrent tumors uncovers novel variance effects in relapses.Acta Neuropathol Commun2023
37004196Reply to Li and Colleagues.J Natl Cancer Inst2023
37188167Clinical outcome following surgical resection and radiotherapy in adult patients with pleomorphic xanthoastrocytoma as defined by DNA methylation profiling.Neurooncol Pract2023
37379234Clinical outcome of pediatric medulloblastoma patients with Li-Fraumeni syndrome.Neuro Oncol2023
37183219Class I HDAC inhibitor entinostat synergizes with PLK1 inhibitors in MYC-amplified medulloblastoma cells.J Neurooncol2023
36933012Glioneuronal tumor with ATRX alteration, kinase fusion and anaplastic features (GTAKA): a molecularly distinct brain tumor type with recurrent NTRK gene fusions.Acta Neuropathol2023
36542877Molecular diagnostics enables detection of actionable targets: the Pediatric Targeted Therapy 2.0 registry.Eur J Cancer2023
36928815Multiomic neuropathology improves diagnostic accuracy in pediatric neuro-oncology.Nat Med2023
37364231Outcome of Children and Adolescents With Relapsed/Refractory/Progressive Malignancies Treated With Molecularly Informed Targeted Drugs in the Pediatric Precision Oncology Registry INFORM.JCO Precis Oncol2023
36459208Identification of low and very high-risk patients with non-WNT/non-SHH medulloblastoma by improved clinico-molecular stratification of the HIT2000 and I-HIT-MED cohorts.Acta Neuropathol2023
37293256Analysis of recurrence probability following radiotherapy in patients with CNS WHO grade 2 meningioma using integrated molecular-morphologic classification.Neurooncol Adv2023
36786841Correction to: Amplification of the PLAG-family genes-PLAGL1 and PLAGL2-is a key feature of the novel tumor type CNS embryonal tumor with PLAGL amplification.Acta Neuropathol2023
37517472Implementation of DNA Methylation Array Profiling in Pediatric Central Nervous System Tumors: The AIM BRAIN Project: An Australian and New Zealand Children's Haematology/Oncology Group Study.J Mol Diagn2023
37501103Mitochondrial DNA mutations in Medulloblastoma.Acta Neuropathol Commun2023
37500667MAPK inhibitor sensitivity scores predict sensitivity driven by the immune infiltration in pediatric low-grade gliomas.Nat Commun2023
36916248Optimizing biomarkers for accurate ependymoma diagnosis, prognostication, and stratification within International Clinical Trials: A BIOMECA study.Neuro Oncol2023
37517472Implementation of DNA Methylation Array Profiling in Pediatric Central Nervous System Tumors: The AIM BRAIN Project: An Australian and New Zealand Children's Haematology/Oncology Group Study.J Mol Diagn2023
37999877Generation of patient-derived pediatric pilocytic astrocytoma in-vitro models using SV40 large T: evaluation of a modeling workflow.J Neurooncol2023
37776353Genetical and epigenetical profiling identifies two subgroups of pineal parenchymal tumors of intermediate differentiation (PPTID) with distinct molecular, histological and clinical characteristics.Acta Neuropathol2023
37501103Mitochondrial DNA mutations in Medulloblastoma.Acta Neuropathol Commun2023
37500667MAPK inhibitor sensitivity scores predict sensitivity driven by the immune infiltration in pediatric low-grade gliomas.Nat Commun2023
37679810Transcriptional immunogenomic analysis reveals distinct immunological clusters in paediatric nervous system tumours.Genome Med2023
36959034Corrigendum to 'Molecular diagnostics enables detection of actionable targets: the Pediatric Targeted Therapy 2.0 registry' [Eur J Cancer 180 (2023) 71-84].Eur J Cancer2023
  • 1 - 50 of 1,080

Recommended Authors

College of Medicine, The Ohio State University
Career Start Year 2017
Number of shared co-authors 11
St. Jude Children's Research Hospital
Career Start Year 2017
Number of shared co-authors 31
Princess Margaret Cancer Centre, University Health Network and University of Toronto
Career Start Year 2016
Number of shared co-authors 13
Children's Hospital of Philadelphia
Career Start Year 2016
Number of shared co-authors 38
Korea University, College of Medicine
Career Start Year 2015
Number of shared co-authors 20
Yale School of Medicine
Career Start Year 2015
Number of shared co-authors 1
Center for Data-Driven Discovery in Biomedicine, Children's Hospital of Philadelphia
Career Start Year 2014
Number of shared co-authors 35
University of California San Francisco
Career Start Year 2014
Number of shared co-authors 24
National Cancer Institute
Career Start Year 2013
Number of shared co-authors 45
Center for Data-Driven Discovery in Biomedicine, Children's Hospital of Philadelphia
Career Start Year 2012
Number of shared co-authors 32
The Hong Kong University of Science and Technology
Career Start Year 2012
Number of shared co-authors 16
Hospital for Sick Children
Career Start Year 2011
Number of shared co-authors 23
University of California
Career Start Year 2010
Number of shared co-authors 9
Institut Curie Hospital
Career Start Year 2010
Number of shared co-authors 21
University of California san francisco
Career Start Year 2010
Number of shared co-authors 35
National Cancer Institute
Career Start Year 2009
Number of shared co-authors 41
Maharaja Agrasen Medical College
Career Start Year 2009
Number of shared co-authors 33
Children's Hospital of Philadelphia
Career Start Year 2008
Number of shared co-authors 51
McMaster Stem Cell and Cancer Research Institute
Career Start Year 2006
Number of shared co-authors 25
Henry Ford Hospital
Career Start Year 2003
Number of shared co-authors 53
MacKay Memorial Hospital
Career Start Year 2003
Number of shared co-authors 21
Perelman School of Medicine at the University of Pennsylvania
Career Start Year 2002
Number of shared co-authors 31
Institut Curie Hospital
Career Start Year 2001
Number of shared co-authors 45
Center for Cancer Research, National Cancer Institute
Career Start Year 2001
Number of shared co-authors 34
Institut Curie
Career Start Year 2000
Number of shared co-authors 27
Pediatric Oncology Institute (IOP/GRAACC), Federal University of Sao Paulo
Career Start Year 1999
Number of shared co-authors 8
St. Jude Children's Research Hospital
Career Start Year 1999
Number of shared co-authors 44
Perelman School of Medicine, University of Pennsylvania
Career Start Year 1994
Number of shared co-authors 51
Stanford University
Career Start Year 1994
Number of shared co-authors 46
Children's Hospital of Philadelphia
Career Start Year 1985
Number of shared co-authors 98

Collaborators

Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers 262
Institute of Pathology, University Hospital Heidelberg
Co-authored papers 233
Hopp Children's Cancer Center (KiTZ)
Co-authored papers 198
Co-authored papers 180
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers 121
The Hospital for Sick Children
Co-authored papers 106
German Cancer Research Center (DKFZ)
Co-authored papers 102
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers 98
Charite University Medicine Berlin
Co-authored papers 98
St Jude Children's Research Hospital
Co-authored papers 96
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers 87
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers 80
Co-authored papers 77
and Clinical Immunology, Heinrich Heine University, University Hospital Dusseldorf
Co-authored papers 74
Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg University
Co-authored papers 68
University Medical Center Hamburg-Eppendorf
Co-authored papers 67
Co-authored papers 65
McGill University Health Centre (MUHC), Montreal Children's Hospital (MCH)
Co-authored papers 62
Co-authored papers 62
N.N. Burdenko Neurosurgical Institute
Co-authored papers 61
Co-authored papers 60
Heinrich Heine University
Co-authored papers 58
University Medical Center Hamburg-Eppendorf
Co-authored papers 54
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers 49
Hospital for Sick Children
Co-authored papers 48
Co-authored papers 45
The Hospital for Sick Children
Co-authored papers 40
St. Jude Children's Research Hospital
Co-authored papers 40
Co-authored papers 36
Co-authored papers 35